2849 results found
In conjunction with the Australian Clinical Trials Alliance, we developed the clinical trials competencies to be used in the development of detailed curricula and training courses by universities, Colleges and other registered training organisations*.
To improve clinical trial start-up times, we developed the Good Practice Process for Site Assessment and Authorisation Phases of Clinical Trial Research Governance (the Good Practice Process).
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
The Statement on consumer and community involvement in health and medical research (The Statement), co-authored by the National Health and Medical Research Council (NHMRC) and the Consumers Health Forum of Australia (CHF), aims to guide research institutions, researchers, consumers and community members in the active involvement of consumers and community members in all aspects of health and medical research.
The Australian Government's Boosting Dementia Research Initiative invested $200 million over 5 years from 2014 to 2019 to accelerate research, enhance collaboration and promote advances in dementia research and treatment. The Boosting Dementia Research Initiative (BDRI) consisted of two main elements:
The Targeted Call for Research (TCR): Anal Cancer 2025 grant opportunity aims to fund research aimed at improving awareness and to provide further guidance for the prevention, diagnosis and treatment of anal cancer for both consumers and healthcare professionals. Its focus may encompass, but is not limited to, the development and implementation of screening methods, innovative prevention strategies, testing technologies, and health promotion approaches to more broadly address anal cancer.